BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6700799)

  • 21. Cutaneous delayed hypersensitivity in patients with colorectal cancer: application of multi-test.
    Papatheodorou K; Triantafillidis JK; Kogevinas M; Manoussakis K; Nicolakis D; Merikas E
    Ital J Gastroenterol; 1994; 26(1):12-5. PubMed ID: 8025300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNCB and PPD skin tests and prognosis in 152 patients with breast cancer. A prospective 2-year follow-up.
    Munzarová M; Kovarík J; Hlávková J; Popelínský L; Lauerová L
    Neoplasma; 1985; 32(1):45-50. PubMed ID: 3982560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
    Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of a human embryonic antigen complex in studying the immune response in cancer patients].
    Gorodilova VV; Mandrik EV; Ul'chenko VM
    Vopr Onkol; 1982; 28(1):23-7. PubMed ID: 7199781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human breast cancer. A model for cancer immunology.
    Black MM
    Isr J Med Sci; 1973 Mar; 9(3):284-99. PubMed ID: 4575653
    [No Abstract]   [Full Text] [Related]  

  • 26. [Breast cancer: a dynamic approach of cellular immunity and immunostimulation with an immunoadjuvant: P40 fraction. (author's transl)].
    Santus JP; Henocq E; Bizzini B; Bazin JC; Mogenet M; Villet R; Reynier J
    Pathol Biol (Paris); 1979 Sep; 27(7):395-401. PubMed ID: 388318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed cutaneous hypersensitivity reaction in breast cancer patients.
    Jain P; Khanna NN
    J Indian Med Assoc; 1988 Jan; 86(1):5-7. PubMed ID: 3288701
    [No Abstract]   [Full Text] [Related]  

  • 28. Demonstration of tumor-associated delayed cutaneous hypersensitivity reactions in patients with lung cancer and in pateients with carcinoma of the cervix.
    Wells SA; Burdick JF; Christiansen C; Ketcham AS; Adkins PC
    Natl Cancer Inst Monogr; 1973 Jun; 37():197-203. PubMed ID: 4713780
    [No Abstract]   [Full Text] [Related]  

  • 29. [Delayed hypersensitivity in pediatric patients with cancer].
    Rivera Luna R; Munford DM; Wilbur JR
    Bol Med Hosp Infant Mex; 1977; 34(6):11-71. PubMed ID: 588329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-mediated immunity in patients with tumors of the female genital tract.
    Zulli P
    Patol Clin Ostet Ginecol; 1977; 5(4):165-74. PubMed ID: 606604
    [No Abstract]   [Full Text] [Related]  

  • 31. Immune status in patients cured of breast and gynaecological cancer.
    Haim N; Rudik L; Samuelly B; Mekori T; Robinson E
    Clin Oncol; 1981 Jun; 7(2):141-7. PubMed ID: 7249436
    [No Abstract]   [Full Text] [Related]  

  • 32. [Delayed hypersensitivity reactions in cancer patients: influence of the clinical stage and chemo- and radiotherapy on the immune status].
    Bouckenaere-Wojcik D; Delzenne G; Deckers C
    Bull Cancer; 1982; 69(5):468-75. PubMed ID: 7165809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Skin tests of delayed hypersensitivity (tuberculin, DNCB) in the immunologic study of patients with primary cancer of the lung].
    Bariffi F; Illiano A; Tranfa CM; Del Prato B
    Arch Monaldi; 1978; 33(4):239-50. PubMed ID: 756707
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cutaneous delayed hypersensitivity to costus root oil in lung cancer].
    Takanami I; Ishihara T; Yanai N
    Gan No Rinsho; 1985 Sep; 31(11):1362-6. PubMed ID: 4068238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Delayed skin reaction in a group of 400 hospital patients: control study (author's transl)].
    Orriols R; Morell F; Fité E; Ruiz J; Tornos C; Sanz R; Morera J
    Med Clin (Barc); 1981 Oct; 77(6):240-2. PubMed ID: 7321638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A possible role for cross-reacting antigens in conditioning immunological surveillance mechanisms in cancer and transplantation. II. Prospective studies of altered cellular immune reactivity in cancer patients.
    Rapaport FT; Lawrence HS
    Transplant Proc; 1975 Jun; 7(2):281-5. PubMed ID: 1129846
    [No Abstract]   [Full Text] [Related]  

  • 37. A study of host defence reaction of breast carcinoma and its correlation with generalised delayed hypersensitivity.
    Nagar R; Maheshwari HB; Mukerjee P; Mittal MM
    Indian J Cancer; 1978 Sep; 15(3):63-8. PubMed ID: 757408
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies of tumor-specific and herpesvirus nonvirion antigens.
    Hollinshead A; Tarro G; Foster WA; Seigel LJ; Jaffurs W
    Cancer Res; 1974 May; 34(5):1122-5. PubMed ID: 4842911
    [No Abstract]   [Full Text] [Related]  

  • 39. Isolation and identification of soluble skin-reactive membrane antigens of malignant and normal human breast cells.
    Hollinshead AC; Jaffurs WT; Alpert LK; Harris JE; Herberman RB
    Cancer Res; 1974 Nov; 34(11):2961-8. PubMed ID: 4138143
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immunological study in cancer of the breast].
    Daban A; Schneider M; Calle R
    Bull Cancer; 1975; 62(1):21-8. PubMed ID: 1222319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.